HIF-1α expression in serum from HCC patients was magnificently increased 1 day after receiving TACE and the peak values were observed at the 7th day after TACE, which was followed by a subsequent decrease with sustained higher level than pre-TACE25. This evidence concerns the gene HIF1A and hepatocellular carcinoma.